Workflow
Clinical trials
icon
Search documents
Ascentage Pharma Group International(AAPG) - Prospectus(update)
2025-01-21 11:06
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 21, 2025 Registration No. 333-284064 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ASCENTAGE PHARMA GROUP INTERNATIONAL (Exact name of Registrant as specified in its charter) Cayman Islands (State or Other Jurisdiction of Incorporation or Organization) 2834 (Primary Standard Industrial Classification Code Number) Not A ...
NeOnc Technologies Holdings Inc(NTHI) - Prospectus
2025-01-03 11:06
As filed with the Securities and Exchange Commission on January 2, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NeOnc Technologies Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 92-1954864 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 2 Dole ...
Inhibikase Therapeutics(IKT) - Prospectus
2024-04-19 21:14
Table of Contents As filed with the Securities and Exchange Commission on April 19, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INHIBIKASE THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2836 26-3407249 (Primary Standard Industrial Classification Code Number) 3350 Riverwood Parkway SE, Suite 1 ...
Contineum Therapeutics, Inc.(CTNM) - Prospectus
2024-03-15 21:04
Table of Contents As filed with the Securities and Exchange Commission on March 15, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 CONTINEUM THERAPEUTICS, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 27-1467257 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Nu ...
NeOnc Technologies Holdings Inc(NTHI) - Prospectus(update)
2024-02-22 22:35
As filed with the Securities and Exchange Commission on February 22, 2024. Registration No. 333-276124 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEONC TECHNOLOGIES HOLDINGS, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 92-1954864 (I.R.S. Employer Id ...
Tenax Therapeutics(TENX) - Prospectus(update)
2024-02-01 21:20
S-1/A 1 tenx_s1a.htm FORM S-1/A As filed with the U.S. Securities and Exchange Commission on February 1, 2024 Registration No. 333-275856 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tenax Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 26-2593535 (Primary Standard Industrial Classification Code Nu ...
Aptose Biosciences(APTO) - Prospectus(update)
2024-01-20 02:50
Table of Contents As filed with the Securities and Exchange Commission on January 19, 2024 Registration No. 333-275870 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 APTOSE BIOSCIENCES INC. (Exact Name of Registrant As Specified In Its Charter) (State or other jurisdiction of incorporation or organization) Canada 2836 98-1136802 (Primary Standard Industrial Classification Code Number) (I.R.S. Employe ...
NeOnc Technologies Holdings Inc(NTHI) - Prospectus
2023-12-18 22:26
As filed with the Securities and Exchange Commission on December 18, 2023. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEONC TECHNOLOGIES HOLDINGS, INC. (Exact name of Registrant as specified in its charter) | Delaware | 2834 | 92-1954864 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporation or organization) | Classification ...
Tenax Therapeutics(TENX) - Prospectus
2023-12-01 21:47
S-1 1 tenx_s1.htm FORM S-1 As filed with the U.S. Securities and Exchange Commission on December 1, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tenax Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 26-2593535 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identi ...
EVOFEM BIOSCIENC(EVFM) - Prospectus(update)
2023-08-03 21:31
As filed with the Securities and Exchange Commission on August 3, 2023 Registration Statement No. 333-273185 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Delaware 2834 20-8527075 (I.R.S. Employer Identification Number) Under THE SECURITIES ACT OF 1933 EVOFEM BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Washington, D.C. 20549 AMENDMENT No. 1 To FORM S-1 REGIS ...